Drugs News

Teva Pharmaceuticals and Blackstone Life Sciences have agreed on a substantial $400 million strategic funding collaboration designed to advance duvakitug through crucial clinical development phases. T... Read the news

The U.S. Food and Drug Administration approved zongertinib for adults with unresectable or metastatic non-squamous non-small cell lung cancer. This decision expands targeted treatment options for pati... Read the news

Johnson & Johnson is expanding U.S. manufacturing with a new cell therapy facility in Pennsylvania. This move could reshape advanced medicine production. The company plans to invest more than $1 b... Read the news

The U.S. Food and Drug Administration has approved ACCRUFeR® (ferric maltol), developed by Shield Therapeutics, as the first and only prescription oral iron therapy for children aged 10 years and ... Read the news

In a major oncology development, the U.S. FDA has accepted a supplemental application for Datroway (datopotamab deruxtecan). It has been granted priority review as a first-line therapy for adults with... Read the news

Genentech announced that fenebrutinib reached a major milestone in multiple sclerosis research. The company presented Phase III data at the Americas Committee for Treatment and Research in Multiple Sc... Read the news

India, Pune — Insight Partners announce the publication of a new report titled, "POULTRY VACCINES Market: An In-depth Analysis." This report provides a comprehensive analysis of the gl... Read the news

Paracetamol, or acetaminophen in some countries, is among the most popular over-the-counter drugs in the world used for analgesic and antipyretic purposes. Due to its safety record-as long as it is ta... Read the news